IPO Under-pricing of pharmaceutical companies in China between 2010 and 2015
The extremely high A-share Initial public offerings (IPOs) under-pricing in China’s primary market provides us with a very interesting area of empirical research. This study focuses on the pharmaceutical industry which is a knowledge-based, technology-intensive industry and has become one of the lea...
| Main Author: | |
|---|---|
| Format: | Thesis |
| Language: | English |
| Published: |
2016
|
| Subjects: | |
| Online Access: | http://eprints.intimal.edu.my/936/ http://eprints.intimal.edu.my/936/1/224.pdf |
| _version_ | 1848766604576292864 |
|---|---|
| author | Yu, Meng Hui |
| author_facet | Yu, Meng Hui |
| author_sort | Yu, Meng Hui |
| building | INTI Institutional Repository |
| collection | Online Access |
| description | The extremely high A-share Initial public offerings (IPOs) under-pricing in China’s primary market provides us with a very interesting area of empirical research. This study focuses on the pharmaceutical industry which is a knowledge-based, technology-intensive industry and has become one of the leading industries in China.
Based on regression analysis of 66 pharmaceutical A-shares companies that went public through IPOs at both Shanghai and Shenzhen Stock Exchanges in China during 2010-2015, we find that 89.4% of pharmaceutical firms were undervalued. This study also finds that 1) IPO underpricing is negatively related to the firm size (asset) and positively related to IPO volume; 2) issuing time and underwriter reputation have no impact on IPO underpricing.
The paper further discuss and analyse the potential and analyse the potential and specific factors that may have influence on IPO underpricing due to the pharmacy industry’s particularity, besides these factors have been lacking in the IPO literature. |
| first_indexed | 2025-11-14T11:53:47Z |
| format | Thesis |
| id | intimal-936 |
| institution | INTI International University |
| institution_category | Local University |
| language | English |
| last_indexed | 2025-11-14T11:53:47Z |
| publishDate | 2016 |
| recordtype | eprints |
| repository_type | Digital Repository |
| spelling | intimal-9362017-09-25T06:44:07Z http://eprints.intimal.edu.my/936/ IPO Under-pricing of pharmaceutical companies in China between 2010 and 2015 Yu, Meng Hui HG Finance The extremely high A-share Initial public offerings (IPOs) under-pricing in China’s primary market provides us with a very interesting area of empirical research. This study focuses on the pharmaceutical industry which is a knowledge-based, technology-intensive industry and has become one of the leading industries in China. Based on regression analysis of 66 pharmaceutical A-shares companies that went public through IPOs at both Shanghai and Shenzhen Stock Exchanges in China during 2010-2015, we find that 89.4% of pharmaceutical firms were undervalued. This study also finds that 1) IPO underpricing is negatively related to the firm size (asset) and positively related to IPO volume; 2) issuing time and underwriter reputation have no impact on IPO underpricing. The paper further discuss and analyse the potential and analyse the potential and specific factors that may have influence on IPO underpricing due to the pharmacy industry’s particularity, besides these factors have been lacking in the IPO literature. 2016 Thesis NonPeerReviewed text en http://eprints.intimal.edu.my/936/1/224.pdf Yu, Meng Hui (2016) IPO Under-pricing of pharmaceutical companies in China between 2010 and 2015. Masters thesis, INTI International University. |
| spellingShingle | HG Finance Yu, Meng Hui IPO Under-pricing of pharmaceutical companies in China between 2010 and 2015 |
| title | IPO Under-pricing of pharmaceutical companies in China between 2010 and 2015 |
| title_full | IPO Under-pricing of pharmaceutical companies in China between 2010 and 2015 |
| title_fullStr | IPO Under-pricing of pharmaceutical companies in China between 2010 and 2015 |
| title_full_unstemmed | IPO Under-pricing of pharmaceutical companies in China between 2010 and 2015 |
| title_short | IPO Under-pricing of pharmaceutical companies in China between 2010 and 2015 |
| title_sort | ipo under-pricing of pharmaceutical companies in china between 2010 and 2015 |
| topic | HG Finance |
| url | http://eprints.intimal.edu.my/936/ http://eprints.intimal.edu.my/936/1/224.pdf |